Target intelligence / Profile preview

Ribosomal protein L39 pseudogene 28 (RPL39P28)

Target
RPL39P28
Molecular classification
Other (Pseudogene)
01

Overview

RPL39P28 (ribosomal protein L39 pseudogene 28) is a processed pseudogene in the human genome with homology to the functional ribosomal protein L39 gene (RPL39)[4][2]. Pseudogenes like RPL39P28 arise via retrotransposition events and do not produce functional proteins[2][4]. They are generally non-coding DNA that serves as evolutionary genomic remnants. RPL39P28 has no known biological function, therapeutic relevance, or disease association and is not considered a molecular target for drug development or biomarker use[4][2]. Note: The canonical "ribosomal protein L39" (RPL39) is a component of the cytoplasmic large (60S) ribosomal subunit, but RPL39P28 itself does not produce protein or participate in ribosome function[6][3][4]. The term "pseudogene" indicates the locus is a non-functional copy and not an active participant in cellular processes. Summary: RPL39P28 is a **pseudogene**, not a therapeutically targetable protein, enzyme, receptor, or transporter, and thus is not suitable for inclusion as a drug target or actionable biomarker.

Other names
RPL39_14_1253RPL39P28

Beyond the preview

Go deeper on Ribosomal protein L39 pseudogene 28 (RPL39P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L39 pseudogene 28 (RPL39P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call